Treatment of intractable epistaxis in patients with nasopharyngeal cancer
Aim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.Results: For treating NPC, radiation therapy is the...
Saved in:
Published in | Annals of medicine (Helsinki) Vol. 55; no. 1; p. 2200257 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
12.12.2023
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.Results: For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics.Conclusion: A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy.
Highlights
The mortality rate for carotid blowout following radiotherapy for NPC is high.
Radiation therapy and tumor condition are correlated with epistaxis in NPC.
Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation.
The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion.
Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis. |
---|---|
AbstractList | Aim:
To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).
Methods:
This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.
Results:
For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics.
Conclusion:
A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy.
Highlights
The mortality rate for carotid blowout following radiotherapy for NPC is high.
Radiation therapy and tumor condition are correlated with epistaxis in NPC.
Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation.
The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion.
Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis. AbstractAim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.Results: For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics.Conclusion: A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy.HighlightsThe mortality rate for carotid blowout following radiotherapy for NPC is high.Radiation therapy and tumor condition are correlated with epistaxis in NPC.Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation.The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion.Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis. Aim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy.Results: For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics.Conclusion: A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy. Highlights The mortality rate for carotid blowout following radiotherapy for NPC is high. Radiation therapy and tumor condition are correlated with epistaxis in NPC. Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation. The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion. Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis. To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC). This review focuses on the anatomy and pathophysiology, mechanism, and clinical treatments of epistaxis after NPC radiotherapy. For treating NPC, radiation therapy is the primary therapeutic modality. However, radiotherapy can lead to varied degrees of harm to the neighboring tissues and is correlated with numerous complications. Among these complications, epistaxis is a common occurrence after NPC radiotherapy, owing to damage to the surrounding tissues caused by radiotherapy. Unfortunately, epistaxis, particularly carotid blowout, can have a dangerous course and a high mortality rate. Accurate understanding of epistaxis following radiotherapy, prompt bleeding cessation, and reduction of bleeding volume are key considerations. Nasal tamponade is a crucial rescue treatment, while tracheotomy is an active and effective method. Intravascular balloon embolization is a reliable and effective treatment method for ICA hemorrhage, and vascular embolization is the primary approach for treating external carotid artery maxillary bleeding. Implantation of a covered stent can achieve hemostasis without altering hemodynamics. A comprehensive approach utilizing these methods can improve the success rate of treating nosebleeds following NPC radiotherapy.HighlightsThe mortality rate for carotid blowout following radiotherapy for NPC is high.Radiation therapy and tumor condition are correlated with epistaxis in NPC.Treatment methods for NPC-related epistaxis include posterior nostril tamponade, endoscopic hemostasis, DSA, selective vascular embolization, and stent implantation.The use of a covered stent for NPC-related carotid blowout achieves hemostasis without altering blood perfusion.Effective and timely application of various hemostasis methods is key to improving the success rate of rescue, considering the characteristics of NPC-related epistaxis. |
Author | Ren, Hanru Zhu, Yueqi Yang, Xiaojing Fu, Jie Li, Minghua Zhang, Weitian |
Author_xml | – sequence: 1 givenname: Xiaojing surname: Yang fullname: Yang, Xiaojing organization: Department of Radiation Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine – sequence: 2 givenname: Hanru surname: Ren fullname: Ren, Hanru organization: Department of Orthopedics, Shanghai Pudong Hospital, Pudong Medical Center, Fudan University – sequence: 3 givenname: Minghua surname: Li fullname: Li, Minghua organization: Department of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine – sequence: 4 givenname: Yueqi surname: Zhu fullname: Zhu, Yueqi organization: Department of Diagnostic and Interventional Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine – sequence: 5 givenname: Weitian surname: Zhang fullname: Zhang, Weitian organization: Department of Otorhinolaryngology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine – sequence: 6 givenname: Jie surname: Fu fullname: Fu, Jie organization: Department of Radiation Oncology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37074291$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1v1DAQhi1URLeFnwDKkUuW8WeSE6CKj5UqcSlny3HGu66SeLG9tP33OOy2ohdOlsbPvDOj54KczWFGQt5SWFNo4QM0reRtB2sGjK8ZA2CyeUFWlCtZM1BwRlYLUy_QOblI6RYK01B4Rc55A41gHV2RzU1EkyeccxVc5eccjc2mH7HCvU_Z3PtUqtXeZF-YVN35vKtmk8J-Z-LDvEUzVtbMFuNr8tKZMeGb03tJfn79cnP1vb7-8W1z9fm6tqLluZaoOgqyV9SicIAGqGBD-eqxkcIqxzgq7iR3VvacK-oGU-6gSnZM9ZbyS7I55g7B3Op99FNZRAfj9d9CiFttYvZ2RG0Uo12npAPaiabnpkMhmUQpWjkI25Ssj8es_aGfcLC43D8-C33-M_ud3obfmgJlICSUhPenhBh-HTBlPflkcRzNjOGQNGuBc77YKag8ojaGlCK6pzkU9OJUPzrVi1N9clr63v275FPXo8QCfDoCfnYhTuYuxHHQ2TyMIbpY5Pik-f9n_AHhRLIu |
Cites_doi | 10.1001/archotol.128.3.280 10.1016/j.ijrobp.2011.07.006 10.1055/s-0038-1676660 10.2147/CMAR.S283968 10.1016/j.asjsur.2022.02.058 10.1038/srep32883 10.1016/S0140-6736(19)30956-0 10.2307/3579031 10.1002/lary.24721 10.1016/j.ijrobp.2017.11.038 10.1016/j.oraloncology.2019.02.023 10.1002/hed.21558 10.1002/hed.25988 10.5603/FM.a2021.0124 10.1177/17085381211020927 10.1007/s00234-006-0127-7 10.1016/j.critrevonc.2020.103088 10.18632/oncotarget.15896 10.1177/2150135118817309 10.1002/hed.25018 10.1002/lary.29119 10.3389/fneur.2020.554988 10.1093/jrr/rrac012 10.21037/cco.2016.03.19 10.1002/(SICI)1097-0347(200005)22:3<215::AID-HED2>3.0.CO;2-B 10.1002/hed.20161 10.1002/hed.21585 10.1007/s11060-020-03462-3 10.1007/s10147-017-1143-9 10.1056/NEJMoa2118191 10.1001/jamaneurol.2018.4165 10.1016/j.ijrobp.2010.08.029 10.5455/medarh.2020.74.139-141 10.2147/CMAR.S183537 10.1158/1055-9965.EPI-20-1702 10.1177/0194599820963129 10.1055/s-0034-1395488 10.1002/hed.21091 10.1007/s00405-016-4339-0 10.3109/02841867809127916 10.1016/j.radcr.2022.03.070 10.1016/j.radonc.2009.10.018 10.1371/journal.pone.0073918 10.1016/j.wneu.2020.02.113 10.1002/cncr.33197 10.1016/j.ijrobp.2011.02.054 10.1080/00016480701813806 10.3389/fneur.2021.739222 10.3390/jcm11072011 10.1024/0301-1526/a000572 10.1038/s41598-021-87170-6 10.1007/s00405-021-07111-x 10.2147/OTT.S44214 10.1016/j.anl.2022.01.006 10.1002/hed.24645 10.1016/j.amjoto.2020.102860 10.1016/S0360-3016(02)02760-8 10.1002/cncr.28934 10.1186/1758-3284-1-13 10.1007/s00062-019-00867-0 |
ContentType | Journal Article |
Copyright | 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 The Author(s) |
Copyright_xml | – notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 – notice: 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 The Author(s) |
DBID | 0YH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1080/07853890.2023.2200257 |
DatabaseName | Taylor & Francis Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 0YH name: Taylor & Francis Open Access url: https://www.tandfonline.com sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | X. Yang et al |
EISSN | 1365-2060 |
EndPage | 2200257 |
ExternalDocumentID | oai_doaj_org_article_a6219965f01947b3a9e4525e5485d4c7 10_1080_07853890_2023_2200257 37074291 2200257 |
Genre | Oncology Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- 00X 03L 0R~ 0YH 23M 36B 4.4 5GY 5RE AAJNR AALUX AAPXX ABBKH ABLKL ABUPF ACENM ACFUF ACGEJ ACGFS ADCVX ADFCX ADRBQ ADXPE AENEX AEOZL AEYQI AFKVX AIJEM AIRBT AJWEG ALIIL ALMA_UNASSIGNED_HOLDINGS BABNJ BLEHA BOHLJ CCCUG CS3 CYYVM DKSSO EBD EBS EMB EMOBN F5P GROUPED_DOAJ HZ~ KRBQP KSSTO KWAYT KYCEM LJTGL O9- OK1 P2P RPM SV3 TFDNU TFL TFW V1S WH7 ~1N .55 .GJ 34G 39C 3O- 53G 5VS AALIY AAORF ABWCV ABZEW ADFZZ AFFNX AFLEI AGYJP AJVHN AWYRJ BRMBE CAG CGR COF CUY CVF CZDIS DRXRE DWTOO ECM EIF EJD H13 JENTW M44 M4Z NPM NUSFT OVD QQXMO TDBHL TEORI X7M ZGI ZXP AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c483t-5e69105b61ce4f0ea0142d483be754c6f23e63f53fc5b3361fda078165926bc13 |
IEDL.DBID | RPM |
ISSN | 0785-3890 |
IngestDate | Tue Oct 22 15:15:38 EDT 2024 Tue Sep 17 21:30:50 EDT 2024 Sat Oct 05 05:31:01 EDT 2024 Fri Aug 23 02:08:16 EDT 2024 Sat Sep 28 08:19:48 EDT 2024 Tue Jul 04 18:16:34 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | radiotherapy Nasopharyngeal cancer covered stent carotid blowout epistaxis |
Language | English |
License | open-access: http://creativecommons.org/licenses/by-nc/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c483t-5e69105b61ce4f0ea0142d483be754c6f23e63f53fc5b3361fda078165926bc13 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 These authors have made equal contributions. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120450/ |
PMID | 37074291 |
PQID | 2803332002 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10120450 pubmed_primary_37074291 informaworld_taylorfrancis_310_1080_07853890_2023_2200257 doaj_primary_oai_doaj_org_article_a6219965f01947b3a9e4525e5485d4c7 crossref_primary_10_1080_07853890_2023_2200257 proquest_miscellaneous_2803332002 |
PublicationCentury | 2000 |
PublicationDate | 2023-12-12 |
PublicationDateYYYYMMDD | 2023-12-12 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-12 day: 12 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Annals of medicine (Helsinki) |
PublicationTitleAlternate | Ann Med |
PublicationYear | 2023 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | e_1_3_3_52_1 e_1_3_3_71_1 Zhao ZY (e_1_3_3_41_1) 2020; 55 e_1_3_3_18_1 e_1_3_3_39_1 e_1_3_3_14_1 e_1_3_3_37_1 e_1_3_3_16_1 e_1_3_3_58_1 e_1_3_3_10_1 e_1_3_3_56_1 e_1_3_3_12_1 e_1_3_3_31_1 e_1_3_3_54_1 e_1_3_3_40_1 e_1_3_3_63_1 Sahan M (e_1_3_3_48_1) 2014; 165 e_1_3_3_7_1 e_1_3_3_9_1 e_1_3_3_29_1 e_1_3_3_25_1 Ay N (e_1_3_3_35_1) 2021; 2021 Lan G (e_1_3_3_50_1) 2016; 51 e_1_3_3_27_1 e_1_3_3_46_1 e_1_3_3_69_1 e_1_3_3_3_1 e_1_3_3_21_1 e_1_3_3_44_1 e_1_3_3_67_1 Tsai HM (e_1_3_3_49_1) 2002; 65 e_1_3_3_5_1 e_1_3_3_23_1 e_1_3_3_42_1 e_1_3_3_65_1 e_1_3_3_30_1 e_1_3_3_51_1 e_1_3_3_17_1 e_1_3_3_19_1 e_1_3_3_13_1 e_1_3_3_38_1 e_1_3_3_59_1 e_1_3_3_15_1 e_1_3_3_36_1 e_1_3_3_57_1 e_1_3_3_34_1 e_1_3_3_55_1 Gu Y (e_1_3_3_61_1) 2020; 3 e_1_3_3_11_1 e_1_3_3_32_1 e_1_3_3_53_1 e_1_3_3_62_1 He CC (e_1_3_3_70_1) 2012; 47 Wang H (e_1_3_3_60_1) 2022; 102 Wu P (e_1_3_3_33_1) 2021; 35 e_1_3_3_6_1 e_1_3_3_8_1 e_1_3_3_28_1 Yau S. (e_1_3_3_47_1) 2015; 44 e_1_3_3_24_1 e_1_3_3_26_1 e_1_3_3_68_1 e_1_3_3_2_1 e_1_3_3_20_1 e_1_3_3_45_1 e_1_3_3_66_1 e_1_3_3_4_1 e_1_3_3_22_1 e_1_3_3_43_1 e_1_3_3_64_1 |
References_xml | – ident: e_1_3_3_13_1 doi: 10.1001/archotol.128.3.280 – ident: e_1_3_3_21_1 doi: 10.1016/j.ijrobp.2011.07.006 – ident: e_1_3_3_56_1 doi: 10.1055/s-0038-1676660 – ident: e_1_3_3_46_1 doi: 10.2147/CMAR.S283968 – ident: e_1_3_3_57_1 doi: 10.1016/j.asjsur.2022.02.058 – ident: e_1_3_3_24_1 doi: 10.1038/srep32883 – ident: e_1_3_3_34_1 doi: 10.1016/S0140-6736(19)30956-0 – ident: e_1_3_3_45_1 doi: 10.2307/3579031 – ident: e_1_3_3_43_1 doi: 10.1002/lary.24721 – ident: e_1_3_3_29_1 doi: 10.1016/j.ijrobp.2017.11.038 – ident: e_1_3_3_69_1 doi: 10.1016/j.oraloncology.2019.02.023 – volume: 47 start-page: 191 issue: 3 year: 2012 ident: e_1_3_3_70_1 article-title: Management of intractable epistaxis and bleeding points localization of post-therapy nasopharyngeal carcinoma publication-title: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi contributor: fullname: He CC – ident: e_1_3_3_19_1 doi: 10.1002/hed.21558 – ident: e_1_3_3_30_1 doi: 10.1002/hed.25988 – ident: e_1_3_3_38_1 doi: 10.5603/FM.a2021.0124 – ident: e_1_3_3_51_1 doi: 10.1177/17085381211020927 – volume: 55 start-page: 671 issue: 7 year: 2020 ident: e_1_3_3_41_1 article-title: [Evaluation and embolization strategy by ASITN/SIR grade for injured internal carotid artery of nasopharyngeal carcinoma] publication-title: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi contributor: fullname: Zhao ZY – ident: e_1_3_3_59_1 doi: 10.1007/s00234-006-0127-7 – ident: e_1_3_3_53_1 doi: 10.1016/j.critrevonc.2020.103088 – ident: e_1_3_3_26_1 doi: 10.18632/oncotarget.15896 – volume: 102 start-page: 1119 issue: 15 year: 2022 ident: e_1_3_3_60_1 article-title: Willis covered stent for paraclinoid aneurysms:efficacy and mid-long-term follow-up results publication-title: Zhonghua Yi Xue Za Zhi contributor: fullname: Wang H – ident: e_1_3_3_58_1 doi: 10.1177/2150135118817309 – ident: e_1_3_3_62_1 doi: 10.1002/hed.25018 – ident: e_1_3_3_36_1 doi: 10.1002/lary.29119 – ident: e_1_3_3_66_1 doi: 10.3389/fneur.2020.554988 – ident: e_1_3_3_31_1 doi: 10.1093/jrr/rrac012 – volume: 2021 start-page: 4270441 year: 2021 ident: e_1_3_3_35_1 article-title: Nasopharyngeal coil dislocation of an embolized internal carotid artery pseudoaneurysm publication-title: Case Rep Otolaryngol contributor: fullname: Ay N – ident: e_1_3_3_10_1 doi: 10.21037/cco.2016.03.19 – ident: e_1_3_3_12_1 doi: 10.1002/(SICI)1097-0347(200005)22:3<215::AID-HED2>3.0.CO;2-B – ident: e_1_3_3_6_1 doi: 10.1002/hed.20161 – volume: 65 start-page: 529 issue: 11 year: 2002 ident: e_1_3_3_49_1 article-title: Transnasal sphenopalatine artery electrocautery for posterior epistaxis publication-title: Zhonghua Yi Xue Za Zhi contributor: fullname: Tsai HM – ident: e_1_3_3_18_1 doi: 10.1002/hed.21585 – ident: e_1_3_3_32_1 doi: 10.1007/s11060-020-03462-3 – ident: e_1_3_3_25_1 doi: 10.1007/s10147-017-1143-9 – ident: e_1_3_3_54_1 doi: 10.1056/NEJMoa2118191 – ident: e_1_3_3_55_1 doi: 10.1001/jamaneurol.2018.4165 – volume: 51 start-page: 367 issue: 5 year: 2016 ident: e_1_3_3_50_1 article-title: The clinical experience of transnasal endoscopic approach for skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma publication-title: Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi contributor: fullname: Lan G – ident: e_1_3_3_9_1 doi: 10.1016/j.ijrobp.2010.08.029 – ident: e_1_3_3_40_1 doi: 10.5455/medarh.2020.74.139-141 – ident: e_1_3_3_42_1 doi: 10.2147/CMAR.S183537 – volume: 165 start-page: e24-7 issue: 1 year: 2014 ident: e_1_3_3_48_1 article-title: Is nasal packing required in epistaxis? publication-title: Clin Ter contributor: fullname: Sahan M – ident: e_1_3_3_2_1 doi: 10.1158/1055-9965.EPI-20-1702 – ident: e_1_3_3_37_1 doi: 10.1177/0194599820963129 – ident: e_1_3_3_39_1 doi: 10.1055/s-0034-1395488 – ident: e_1_3_3_15_1 doi: 10.1002/hed.21091 – ident: e_1_3_3_28_1 doi: 10.1007/s00405-016-4339-0 – ident: e_1_3_3_44_1 doi: 10.3109/02841867809127916 – ident: e_1_3_3_63_1 doi: 10.1016/j.radcr.2022.03.070 – ident: e_1_3_3_16_1 doi: 10.1016/j.radonc.2009.10.018 – volume: 3 start-page: 184 issue: 4 year: 2020 ident: e_1_3_3_61_1 article-title: Reconstructive treatment of symptomatic vertebral artery dissecting aneurysms with Willis covered stent: initial experience publication-title: J Interv Med contributor: fullname: Gu Y – ident: e_1_3_3_22_1 doi: 10.1371/journal.pone.0073918 – ident: e_1_3_3_67_1 doi: 10.1016/j.wneu.2020.02.113 – ident: e_1_3_3_11_1 doi: 10.1002/cncr.33197 – ident: e_1_3_3_20_1 doi: 10.1016/j.ijrobp.2011.02.054 – volume: 35 start-page: 448 issue: 5 year: 2021 ident: e_1_3_3_33_1 article-title: Extracranial/intracranial vascular bypass to control carotid artery blowout in postirradiated nasopharyngeal carcinoma patients publication-title: Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi contributor: fullname: Wu P – ident: e_1_3_3_14_1 doi: 10.1080/00016480701813806 – ident: e_1_3_3_65_1 doi: 10.3389/fneur.2021.739222 – ident: e_1_3_3_52_1 doi: 10.3390/jcm11072011 – ident: e_1_3_3_64_1 doi: 10.1024/0301-1526/a000572 – ident: e_1_3_3_8_1 doi: 10.1038/s41598-021-87170-6 – ident: e_1_3_3_3_1 doi: 10.1007/s00405-021-07111-x – ident: e_1_3_3_5_1 doi: 10.2147/OTT.S44214 – ident: e_1_3_3_4_1 doi: 10.1016/j.anl.2022.01.006 – ident: e_1_3_3_27_1 doi: 10.1002/hed.24645 – ident: e_1_3_3_68_1 doi: 10.1016/j.amjoto.2020.102860 – ident: e_1_3_3_7_1 doi: 10.1016/S0360-3016(02)02760-8 – ident: e_1_3_3_23_1 doi: 10.1002/cncr.28934 – volume: 44 start-page: 653 issue: 9 year: 2015 ident: e_1_3_3_47_1 article-title: An update on epistaxis publication-title: Aust Fam Physician contributor: fullname: Yau S. – ident: e_1_3_3_17_1 doi: 10.1186/1758-3284-1-13 – ident: e_1_3_3_71_1 doi: 10.1007/s00062-019-00867-0 |
SSID | ssj0002710 |
Score | 2.452521 |
SecondaryResourceType | review_article |
Snippet | Aim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the anatomy... To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC). This review focuses on the anatomy and... Aim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC). Methods: This review focuses on the anatomy... AbstractAim: To investigate the treatment of intractable epistaxis after radiotherapy for nasopharyngeal carcinoma (NPC).Methods: This review focuses on the... |
SourceID | doaj pubmedcentral proquest crossref pubmed informaworld |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2200257 |
SubjectTerms | Carotid Arteries carotid blowout covered stent Embolization, Therapeutic - adverse effects Embolization, Therapeutic - methods epistaxis Epistaxis - complications Epistaxis - therapy Humans Nasopharyngeal cancer Nasopharyngeal Carcinoma - complications Nasopharyngeal Carcinoma - therapy Nasopharyngeal Neoplasms - complications Nasopharyngeal Neoplasms - radiotherapy Oncology radiotherapy Review |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZlDyGX0jzaunmgQq_eWh5Jto5JyJIU0lMCuQlLltq9eJddB5p_nxk_wu5SyCVX2RhpPkvzSTP6hrEf6KGliLVINcg6xVXSp8ZInQpZ17J0ZVF6OtC_-61vHuSvR_W4UeqLcsJ6eeDecD8rnVOirIrIRWThoDKBQnEBmbaqpe_vkWdm3EwNa3BedDoE6P9Uii45G-_ukKo2tlHTlAqHT3NKUiDftOGVOvH-HenS_xHQ3TzKDcc0-8Q-DoySX_QjOWAfQnPI9u6GmPkRu70fc8n5IvI5fcO3dGGKhyWRx3_zNbbyQWB1zelkljcVlTeoVs_NH2SS3NO_sTpmD7Pr-6ubdCigkHpZQpuqoJENKKeFDzJmocL9UI4QgAuFkl7HHIKGqCB65QA0glaR-A-FWrXzAj6zSbNowlfGA5iSLsWZWIKMhXIiz0MGLoLJnNAhYdPRgHbZ62RYMcqPDha3ZHE7WDxhl2Tm15dJ5rprQPDtAL59C_yEmU2QbNudcsS-JImFNzrwfUTU4pSiOEnVhMXT2lLBLgB6K2FfeoRfuwkFHSYYkbByC_utcWw_aeZ_O9luUlJDAp19e4-Rn7B9Ggwl1oj8lE3a1VM4Q3rUuvNuJrwAeW8EwQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Taylor & Francis Open Access dbid: 0YH link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELYolVAviBZaFlpkJK5ZYo_txEdARVuk5bRIcLJix6Z7ya42QYJ_jyePFYta9dBjHMdyZjye8cz4G0LOooYWLJQsUSDKJO6SLtFaqISJshS5zbPcoUN_eqsmd-LmXg7ZhHWfVoln6NABRbR7NQp3YeshI-48arUopjodY-nvMcc0A5l9IB95JttIbfowWW_GPGsBCfCTBL8ZLvH8bZgN9dSi-L_DMP2TJfo-ofKNhrreI7u9aUkvurXwmWz56gvZmfbB833yazYkldNFoHMcwzV4c4r6JVqRz_M6ttIeabWm6KKlVYF1DorVS_UYTUrqcJGsDsjd9c_Z1STpKykkTuTQJNKraBZIq5jzIqS-iAcjHnkB1mdSOBU4eAVBQnDSAqjIvQJRgDDmqqxj8JVsV4vKHxLqQed4O06HHETIpGWc-xRsAJ1apvyIjAcCmmUHmGHYgEPaU9wgxU1P8RG5RDKvOyPedduwWD2aXnxMoTimS8sQLVKRWSi0x4Csj-ctWQoXB9FvmWSa1t0RutokBv4xgdOBoybKFgZMisovnmqDlbsAsNeIfOs4vJ4mZOhV0GxE8g3eb_zH5ptq_rvF70ZItWhJp0f_Melj8gkfMbGG8e9ku1k9-R_RPGrsSSsAr5q7Ats priority: 102 providerName: Taylor & Francis |
Title | Treatment of intractable epistaxis in patients with nasopharyngeal cancer |
URI | https://www.tandfonline.com/doi/abs/10.1080/07853890.2023.2200257 https://www.ncbi.nlm.nih.gov/pubmed/37074291 https://search.proquest.com/docview/2803332002 https://pubmed.ncbi.nlm.nih.gov/PMC10120450 https://doaj.org/article/a6219965f01947b3a9e4525e5485d4c7 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfWPSBeEN90QGUkXpPGOdtJHmFiKkhFPGzSeLJixx6VWFq1mQT_PXduPK0TEhKvF8ey786-s333O8beo4WWInQi0yC7DHdJlzWN1JmQXSdrW1e1owv95Ve9uJBfLtXlEdMpFyYG7Tu7yvuf13m_-hFjKzfXbp7ixObflqeESYWuSDGfsAlqaDqjj_tvWUUMArR9KkNzXKS8HULURhqRcioanpcUoKCoDB9UdERsxIFxihj-9xBM_-aH3g-nvGOfzh6zR6NjyT_sJ_CEHfn-KXuwHJ_On7HP5ymknK8DX1EfbqC8Ke435EP-Wu2Qykec1R2nC1ret1TloN3-7q_QoeSOVGT7nF2cfTo_XWRjHYXMyRqGTHmNToGyWjgvQ-FbPBaVKAmwvlLS6VCC1xAUBKcsgEbZtYQBRC-u2joBL9hxv-79K8Y9NDXlxjWhBhkqZUVZ-gJsgKawQvspyxMDzWYPl2FEQiEdmW-I-WZk_pR9JDbfNia060hYb6_MKHPT6pKCpVVAf1RWFtrG03Osx9OW6qTDTpq7QjJDvOwI-8okBv4xgHdJogZXFj2XtL1f3-wM1e0CoFZT9nIv4dthJoWZsvpA9gfzOPyCyhzRu5Pynvz_r6_ZQ5oCRdWI8g07HrY3_i36RoOdsUnxfTGLNwuzuCz-AKhECJw |
link.rule.ids | 230,315,730,783,787,867,888,2109,27516,27938,27939,53806,53808,59477,59478 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RkNpeqgJ9bJ9G4pptnLGd-NhWRQtlOS0SPVmxY8Nesmg3SOXf48ljtYta9dBr_JAz47HH8_gG4Dje0IKHiicKRZXEU9IlWguVcFFVorBFXjgy6E8v1ORSnF3Jq41cGAqrpDd06IAi2rOahJuM0UNI3Jd4rUU51emYan-PM4ozkPkT2JNa5BTWlf6arE_jLG8RCWhIQmOGLJ6_TbN1P7Uw_o9ATP-kij6OqNy4ok5ewotet2Rfu82wDzu-PoCn0957fginsyGqnC0Cm9McrqHUKeZvSY38PV_Fr6yHWl0xstGyuqRCB-Xyvr6OOiVztEuWr-Dy5Mfs-yTpSykkThTYJNKrqBdIq7jzIqS-jC-jLDIDrc-lcCpk6BUGicFJi6gi-0qCASKnq7KO42vYrRe1fwvMoy4oPU6HAkXIpeVZ5lO0AXVqufIjGA8ENLcdYobhAxBpT3FDFDc9xUfwjci87kyA1-2HxfLa9PJjSpVRvLQMUSUVucVSe_LI-vjgkpVwcRK9ySTTtPaO0BUnMfiPBRwNHDVRuMhjUtZ-cbcyVLoLkXqN4E3H4fUyMSezguYjKLZ4v_Uf2y31_KYF8CZMtahKp-_-Y9Gf4dlkNj0356cXP9_Dc2qiKBuefYDdZnnnP0ZdqbGfWmF4ALOoBk8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BkSouFaWFLrRgpF6zxBnbiY_QdrUFWvXQSnCyYsdu95Jd7aYS_Hs8eay6FYgD1_ghZ8bjGc-MvwE4jhpa8FDxRKGoknhKukRroRIuqkoUtsgLRw79i0s1vRFfvsshm3DVp1XSHTp0QBHtWU3CvajCkBH3MWq1KKY6HVPp73FGaQYyfwrPpBY53b_SH9P1YZzlLSABDUlozPCI52_TbKinFsX_EYbpnyzRxwmVDzTU5AXs9KYl-9TthV144uuXsH3RB8_34Px6SCpn88BmNIdr6OUU8wuyIn_OVvEr65FWV4xctKwuqc5BufxV30aTkjnaJMt9uJmcXZ9Mk76SQuJEgU0ivYpmgbSKOy9C6st4McoiL9D6XAqnQoZeYZAYnLSIKnKvJBQgirkq6zi-gq16XvsDYB51Qa_jdChQhFxanmU-RRtQp5YrP4LxQECz6AAzDB9wSHuKG6K46Sk-gs9E5nVnwrtuP8yXt6YXH1OqjNKlZYgWqcgtltpTQNbH-5ashIuT6IdMMk3r7ghdbRKD_1jAh4GjJsoWBUzK2s_vV4YqdyFSrxG87ji8Xibm5FXQfATFBu83_mOzpZ7dtfjdBKkWLen0zX8s-j1sX51OzLfzy69v4Tm1UI4Nzw5hq1ne-6NoKTX2XSsLvwECJQV4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Treatment+of+intractable+epistaxis+in+patients+with+nasopharyngeal+cancer&rft.jtitle=Annals+of+medicine+%28Helsinki%29&rft.au=Yang%2C+Xiaojing&rft.au=Ren%2C+Hanru&rft.au=Li%2C+Minghua&rft.au=Zhu%2C+Yueqi&rft.date=2023-12-12&rft.eissn=1365-2060&rft.volume=55&rft.issue=1&rft.spage=2200257&rft_id=info:doi/10.1080%2F07853890.2023.2200257&rft_id=info%3Apmid%2F37074291&rft.externalDocID=37074291 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0785-3890&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0785-3890&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0785-3890&client=summon |